• Amlexanox
  • 2336-50
  • 50 mg
An anti-allergy, anti-asthma and anti-diabetic agent. Improves obesity-related metabolic dysfunction in mouse models. Increases thermogenesis and weight loss, decreases steatosis and improves insulin sensitivity. Inhibits TANK-binding kinase 1 (TBK1) and IKKe (IC₅₀ =1.2 µM). Clinically useful in treatment of aphthus ulcers.

相關檔案下載

相關產品